Literature DB >> 26835266

A step forward in acute lymphoblastic leukemia.

Jan Styczynski1.   

Abstract

Entities:  

Year:  2012        PMID： 26835266      PMCID： PMC4728882          DOI： 10.3978/j.issn.2224-4336.2012.08.01

Source DB:  PubMed          Journal:  Transl Pediatr        ISSN： 2224-4336


× No keyword cloud information.
  3 in total

1.  Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.

Authors:  A Möricke; M Zimmermann; A Reiter; H Gadner; E Odenwald; J Harbott; W-D Ludwig; H Riehm; M Schrappe
Journal:  Klin Padiatr       Date:  2005 Nov-Dec       Impact factor: 1.349

2.  Pilot study of nelarabine in combination with intensive chemotherapy in high-risk T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Authors:  Kimberly P Dunsmore; Meenakshi Devidas; Stephen B Linda; Michael J Borowitz; Naomi Winick; Stephen P Hunger; William L Carroll; Bruce M Camitta
Journal:  J Clin Oncol       Date:  2012-06-25       Impact factor: 44.544

3.  Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL.

Authors:  Marja J Willemse; Taku Seriu; Klaudia Hettinger; Elisabetta d'Aniello; Wim C J Hop; E Renate Panzer-Grümayer; Andrea Biondi; Martin Schrappe; Willem A Kamps; Guiseppe Masera; Helmut Gadner; Hansjoerg Riehm; Claus R Bartram; Jacques J M van Dongen
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.